Infectious Disease – COVID 19

NICaS solution closes treatment gaps by providing accurate and continuous cardiorespiratory and fluid data. This enables: efficient patient management, online drug and oxygen titration, optimized treatment, clear understanding of oxygen delivery and recognizing early signs of oxygen delivery failure.


Current protocols advise against mechanical ventilation. This makes managing severe patients extremely challenging due to missing tissue oxygenation parameters.

Limited knowledge about the virus requires closer patient surveillance.

Risk of medical team contamination.


Closes the information gap to enable better treatment strategy.

Provides information remotely without risk to medical teams.

Covid-19 In Numbers:

0.4% mortality rate

Over 6.3 Million deaths worldwide

7-day median hospital stay in ICU resulting in various comorbidities

Related Clinical Markets

Determining the cause of hypertension or hypotension by each patient’s objective hemodynamic
Gestational Hypertension
Determine the exact cause of hypertension for Preeclampsia management
Heart Failure
Providing caretakers with accurate information on patient hemodynamic status

Related Clinical Studies

Contact Us